LEMAITRE VASCULAR INC — Director's Dealing 2025

Mar 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-02-28

Reporting Person: Jasinski Lawrence J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-28	Common Stock	A	204	—	Acquired	5748	Direct
2025-02-28	Common Stock	M	1	—	Acquired	5749	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-28	Dividend Equivalent Rights	$	M	1	Disposed		Common Stock (1)	Direct

Footnotes

F1: These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years.

F2: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.

F3: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F4: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.